Related Experiment Videos
[Surgical treatment for ulcerative colitis--recent advances]
Akira Sugita1, Hideaki Kimura, Katsuhiko Arai
1Department of Surgery, Yokohama Municipal Citizen's Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 11, 2005
Summary
Surgery for ulcerative colitis is indicated for severe cases or when medical treatments fail. New indications are emerging with advanced therapies like leucocytoapheresis and cyclosporine, ensuring timely surgical intervention improves outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Colorectal Surgery
- Inflammatory Bowel Disease Research
Context:
- Ulcerative colitis (UC) management traditionally relies on medical therapies, with surgery reserved for refractory cases.
- Recent advancements in medical treatments, including leucocytoapheresis and intravenous cyclosporine, necessitate a re-evaluation of surgical indications.
- Established surgical procedures like ileal pouch anal anastomosis (IPAA) with rectal mucosal stripping and stapled IPAA offer satisfactory outcomes.
Purpose:
- To discuss the evolving surgical indications for ulcerative colitis in light of new medical treatment options.
- To review standard surgical procedures for ulcerative colitis and their associated outcomes.
- To emphasize the importance of timely surgical intervention for patients unresponsive to medical management.
Summary:
- Current surgical indications for ulcerative colitis include fulminant colitis, intractability, cancer, or dysplasia.
- The advent of novel medical treatments necessitates the establishment of new surgical criteria.
- Ileal pouch anal anastomosis, with or without stapling and rectal mucosal stripping, are standard procedures yielding good postoperative bowel function and quality of life (QOL).
Impact:
- Highlights the need for updated guidelines on surgical intervention in ulcerative colitis.
- Underscores the importance of prompt surgical referral for patients failing medical therapy.
- Contributes to optimizing patient care and outcomes in ulcerative colitis management.